中国癌症防治杂志2016，Vol.8Issue(6)：369-371,372,4.DOI:10.3969/j.issn.1674-5671.2016.06.07
新发脑胶质瘤患者细胞免疫功能与肿瘤WHO分级的关系
Correlation between cellular immunity and WHO classification of newly diagnosed glioma
摘要
Abstract
Objective To investigate the cellular immunity status of glioma patients and their correlation with the WHO classification of gliomas. Methods The clinical data of 92 patients with newly diagnosed patients analyzed retrospectively.Preoperative cellular immunity was measured by flow cytometry and WHO classification of gliomas were confirmed by postoperative pathology. The correlation between cellular immunity and WHO classification of glioma was analyzed by Spearman's rank correlation coefficient. Results No statistically significant differences were observed concerning CD3+,CD4+,CD8+,CD4+/CD8+,CD16+CD56+or CD19+( P<0.05) .No significant correlation between cellular immunity and WHO classification of gliomas were observed by Spearman's rank correlation coefficient( P<0.05) . Conclusions There is no significant correlation between patient's cellular immunity and WHO classification of gliomas. Preoperative cellular immunity test can not differentiate low grade glioma from high grade glioma.关键词
脑胶质瘤/细胞免疫/WHO肿瘤分级Key words
Glioma/Cellular immunity/WHO classification分类
医药卫生引用本文复制引用
邓腾,莫立根,陈海南,曾先捷..新发脑胶质瘤患者细胞免疫功能与肿瘤WHO分级的关系[J].中国癌症防治杂志,2016,8(6):369-371,372,4.基金项目
广西自然科学基金面上项目 （）
